{"key":"op_790_DE","page":{"url":"https://ru.bookimed.com/clinics/country=germany/procedure=targetnaa-terapia-pri-rake-legkih/","procedure":{"id":790,"slug":"targetnaa-terapia-pri-rake-legkih","name":"Таргетная терапия при раке легких","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":22,"iso":"DE","name":"Германия"},"currency":"USD","data_date":"2026-09-25"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=germany/procedure=targetnaa-terapia-pri-rake-legkih/","cost_url":"https://ru.bookimed.com/clinics/country=germany/procedure=targetnaa-terapia-pri-rake-legkih/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":3000,"to":27000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":90000,"to":150000},"uk":{"from":14000,"to":25000},"by_technique":[{"technique":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","technique_id":"oral-egfr-tyrosine","price_from":6000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","technique_id":"other-oral-targeted","price_from":5500,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","technique_id":"antibody-based-targeted","price_from":9000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Золинген","from":3000},{"city":"Бремен","from":11200},{"city":"Гамбург","from":8500},{"city":"Берлин","from":6500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":3500,"to":7000},{"country_iso":"FR","from":6500,"to":13000},{"country_iso":"GB","from":14000,"to":25000},{"country_iso":"US","from":90000,"to":150000},{"country_iso":"IL","from":9000,"to":16000},{"country_iso":"TR","from":5000,"to":5800},{"country_iso":"MX","from":6500,"to":12000},{"country_iso":"CA","from":9000,"to":20000},{"country_iso":"AE","from":9000,"to":14000},{"country_iso":"TH","from":9000,"to":13500},{"country_iso":"PL","from":4500,"to":8500},{"country_iso":"KR","from":2500,"to":15000},{"country_iso":"CZ","from":4500,"to":9000},{"country_iso":"AT","from":9000,"to":18000},{"country_iso":"ES","from":4500,"to":13000},{"country_iso":"IT","from":8200,"to":15900},{"country_iso":"CN","from":1600,"to":13000},{"country_iso":"AU","from":3800,"to":7500},{"country_iso":"IN","from":1000,"to":5500},{"country_iso":"MY","from":1800,"to":5400},{"country_iso":"VN","from":5000,"to":9500},{"country_iso":"BR","from":4500,"to":7000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":97,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":5,"items":[{"id":268,"name":"Medical Center in Solingen","city":"Solingen","rating":4.7,"reviews_count":69,"accreditations":["Best doctor for herniated disc treatment","German Cancer Society"],"rank":1,"has_procedure":true,"why_ranked":"Dedicated Hematology and Oncology Center conducts clinical research into new cancer therapies, including targeted approaches. German Cancer Society certified and academic teaching hospital of University of Cologne.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":136,"name":"Nordwest Clinic (Krankenhaus)","city":"Frankfurt am Main","rating":4.5,"reviews_count":57,"accreditations":["TÜV AG Company Research & Investing Certificate","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":295,"name":"Bremen-Mitte Clinic","city":"Bremen","rating":4.3,"reviews_count":41,"accreditations":["International Organization for Standardization","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":404,"name":"Bremen-Ost Clinic","city":"Bremen","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Cooperation for transparency and quality in the health service","TOP German hospital according to 2019 Focus ranking"],"rank":4,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":8400,"name":"Westpfalz-Klinikum GmbH","city":"Kaiserslautern","rating":3,"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":{"status":"missing","reason":"not_collected"},"rank":5,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":2,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":341,"slug":"zolingen","name":"Золинген","clinics_count":1,"price_from":3000,"profile":{"city_type":"Bergisches Land city east of Düsseldorf","access":["Düsseldorf Airport (DUS), nearest airport to Solingen"],"sources":["https://en.wikipedia.org/wiki/Solingen"],"checked_at":"2026-11-03","status":"ok"}},{"id":352,"slug":"bremen","name":"Бремен","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":11200,"profile":{"city_type":"Hanseatic port city in northern Germany","access":["Bremen Airport (BRE), 4 km south of the city"],"sources":["https://en.wikipedia.org/wiki/Bremen","https://en.wikipedia.org/wiki/Bremen_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":119,"slug":"gamburg","name":"Гамбург","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":8500,"profile":{"city_type":"Second-largest city in Germany","access":["Hamburg Airport (HAM), 9 km north of city center"],"sources":["https://en.wikipedia.org/wiki/Hamburg","https://en.wikipedia.org/wiki/Hamburg_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":23,"slug":"berlin","name":"Берлин","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":6500,"profile":{"city_type":"Capital and largest city of Germany","access":["Berlin Airport (BER), 18 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Berlin","https://en.wikipedia.org/wiki/Berlin_Brandenburg_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"operation_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"horizon":"First response imaging, about 6 to 12 weeks after first dose","source":{"status":"missing","reason":"not_collected"},"evidence_status":"limited"},"scars":"None; no incisions.","pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":0,"max":7,"unit":"days","qualifier":"No procedure or stay; many patients with good performance status work within a week, adjusted for side effects."},"complication_rate_pct":{"min":1,"max":5,"unit":"percent","qualifier":"Approximate rate of interstitial lung disease or pneumonitis on osimertinib; milder effects like rash and diarrhea are far more common."},"contraindications":["Severe hypersensitivity to osimertinib or its components.","Current interstitial lung disease or pneumonitis.","Congenital long QT syndrome or uncorrectable electrolyte disturbances.","Clinically significant cardiomyopathy or reduced ventricular function.","Strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin, St John's wort).","Pregnancy or planned conception (not recommended)."],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Oral therapy taken at home; no hospital stay in an uncomplicated course. Infusion-based regimens are outside this profile."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":2,"unit":"weeks","qualifier":"Light activity from day 1; strenuous exercise gradually over 1 to 2 weeks if tolerability and breathing allow."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Time to first radiologic response assessment, about 6 to 12 weeks. Not a cure endpoint; therapy continues."},"fly_home_after_days":{"min":0,"max":14,"unit":"days","qualifier":"No procedure; travel is possible after baseline workup, once stable with enough medication. Tolerability review at about 2–4 weeks."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose; tolerability and laboratory review."}},{"purpose":"result_review","requirement":"routine","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; first response imaging and clinic review."}},{"purpose":"assessment","requirement":"routine","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; periodic imaging every 2 to 3 months, later intervals individualized."}}],"indications":["Advanced or metastatic NSCLC with EGFR exon 19 deletion","Advanced or metastatic NSCLC with EGFR L858R mutation","Adjuvant therapy after resection of EGFR-mutated NSCLC","Unresectable stage III EGFR-mutated NSCLC after chemoradiotherapy"],"main_risks":["Diarrhea, dry skin, rash, paronychia, mouth sores; usually manageable.","Interstitial lung disease: rare but serious; stop drug, urgent evaluation.","QT prolongation; rarely reduced heart function.","Low blood counts and liver enzyme changes found on monitoring.","Eye symptoms and rare severe skin reactions.","Drug interactions, especially with CYP3A4 inducers."],"pain":"Taking the oral tablet is painless. Treatment-related discomfort, such as mouth sores, nail-fold tenderness, rash or headache, can occur and is managed symptomatically.","preparation":["Confirm NSCLC and EGFR mutation by tissue or liquid biopsy","Baseline staging, usually CT with brain imaging, per the oncologist.","Baseline blood counts, liver and kidney tests, electrolytes","ECG and cardiac assessment as indicated","Review all medicines and supplements for CYP3A4 and QT interactions.","Counseling on side effects, dosing, skin and nail care","Contraception advice and when to contact the oncology team"],"recovery_timeline":[{"phase":"Treatment start (day 0)","description":"Baseline assessment and counseling, then daily oral osimertinib starts at home. No hospital stay; light activity continues from day 1.","restrictions":["Take the tablet daily as directed","Avoid interacting drugs and supplements unless cleared","Use contraception as advised"]},{"phase":"Days 1 to 28","description":"Mild diarrhea, dry skin, rash, nail changes, mouth sores and fatigue may appear; supportive care helps. Exercise resumes gradually.","restrictions":["Daily skin, nail and mouth care","Maintain hydration","Increase exercise gradually, guided by oncology team"]},{"phase":"Weeks 6 to 12","description":"First response imaging and clinic review; initial response is judged and monitoring continues.","restrictions":["Continue treatment unless the oncology team advises otherwise"]},{"phase":"Ongoing therapy (months 3 to 6 and beyond)","description":"Daily therapy with periodic reviews and imaging until progression or intolerance; repeat testing if disease progresses.","restrictions":["Continue regular monitoring as scheduled","Do not stop or change dose without oncology advice"]},{"phase":"At any time","description":"Seek urgent care for new cough, breathlessness, fever, chest pain, palpitations, severe diarrhea, severe rash, eye pain, or infection or bleeding signs.","restrictions":["Do not wait for the next review","Team may pause the drug during assessment"]}],"rehabilitation_days":{"min":0,"max":7,"unit":"days","qualifier":"Oral therapy without procedure; time to settle into daily routine, affected by rash, diarrhea, fatigue and disease burden."},"result_longevity":"Disease control typically lasts months to a few years until resistance develops; median first-line progression-free survival was roughly 1.5 years. Benefit lasts only during therapy; not a cure.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":4,"max":8,"unit":"visits","qualifier":"Planned oncology reviews in the first 6 months from treatment start."},"stages":[{"code":"baseline_start","label":"Baseline assessment, counseling and start of daily oral therapy","after":{"min":0,"max":0,"unit":"days","qualifier":"Counted from treatment start."}},{"code":"early_tolerability_review","label":"Tolerability and laboratory review","after":{"min":14,"max":28,"unit":"days","qualifier":"After the first dose."}},{"code":"first_response_assessment","label":"First response imaging and clinic review","after":{"min":42,"max":84,"unit":"days","qualifier":"After the first dose; timing varies by clinic."}},{"code":"ongoing_scheduled_reviews","label":"Ongoing reviews with periodic imaging every 2 to 3 months","after":{"min":84,"max":180,"unit":"days","qualifier":"After the first dose; later intervals individualized."}}],"qualifier":"Daily oral osimertinib after biomarker confirmation, continued until progression or intolerance. Counts cover first 6 months only."},"success":{"metric":"Objective response rate (tumor shrinkage on imaging)","value":80,"unit":"percent","horizon":"First response imaging, about 6 to 12 weeks after first dose","population":"Adults with advanced EGFR exon 19 or L858R NSCLC on first-line osimertinib","evidence_status":"limited"},"techniques":[{"name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","suits_whom":"Adults with EGFR-mutated advanced NSCLC.","recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":0.5,"max":3,"unit":"hours","qualifier":"Initial clinic visit for counseling and start; daily tablet takes minutes and therapy continues until progression."},"initial_assessment_documents":["Lung biopsy pathology report","EGFR and other biomarker test report (NGS)","Chest CT or PET-CT report and images","Brain MRI report","Recent blood tests with liver and kidney function","Previous cancer treatment summary (if available)"],"travel_trips":{"min":1,"max":3,"one_trip_possible":true,"qualifier":"Daily oral therapy; one 1-2 week trip covers workup and start; imaging and reviews may need return trips."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that the doctor explains the risks of any biopsy needed for the tumor before it is done","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C2","text":"Check whether the doctor explains that cancer cells can become resistant to targeted therapy","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Cancer cells can become resistant to targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C3","text":"Check the plan for regular visits, blood tests and scans, which show whether the treatment is working","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"These regular visits and tests will help the doctor know whether the treatment is working.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C4","text":"Check that the side effects of the specific targeted drug you would receive are explained before treatment starts","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"The side effects that you may have depends on the type of targeted therapy you receive and how your body reacts to it.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"C5","text":"Check that your tumor has been tested for drug targets, which is needed most of the time","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that the doctor can know for certain how you will feel during treatment","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Doctors and nurses cannot know for certain how you will feel during treatment.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F2","text":"Ad or quote calling targeted therapy free of serious side effects","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But they have learned that targeted therapy can also cause serious side effects.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}},{"id":"F3","text":"Targeted therapy offered without any mention of testing the tumor for drug targets","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W2","text":"Worsening cough","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"W3","text":"Blood in sputum","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"chest discomfort or pain; a cough that doesn't go away or gets worse over time; trouble breathing; wheezing; blood in sputum (mucus coughed up from the lungs)","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"technique_details":{"status":"ok","items":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"EGFR mutation test","aliases":["EGFR mutation test","EGFR mutation","EGFR","tissue biopsy","liquid biopsy","EGFR and other biomarker test"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm NSCLC and EGFR mutation by tissue or liquid biopsy"},{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks for lung tumor gene changes treatable with targeted therapy","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"So, lung cancer genetic tests can help your provider find out whether your cancer has a gene change that may be treated with a targeted therapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Next-generation sequencing (NGS) test","aliases":["Next-generation sequencing (NGS) test","NGS","next-generation sequencing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"EGFR and other biomarker test report (NGS)"}],"what_it_checks":{"text":"Checks several tumor gene changes in one test","source":{"url":"https://medlineplus.gov/lab-tests/lung-cancer-genetic-tests/","host":"medlineplus.gov","quote":"Because there are many types of gene changes that can be involved in NSCLC, your provider may check for several of these changes in one lung cancer genetic test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Monitors blood cell counts that treatment may affect","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"It is also used to monitor a condition or treatment that may affect your blood cell counts such as infections, anemia, immune system disorders, and blood cancers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to fast for several hours if other tests are ordered","source":{"url":"https://medlineplus.gov/lab-tests/complete-blood-count-cbc/","host":"medlineplus.gov","quote":"But if your provider ordered other tests on your blood sample, you may need to fast (not eat or drink) for several hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","liver and kidney tests","liver and kidney function","LFT","Kidney function test","kidney tests","kidney function","RFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"text":"Checks how well the liver works and whether it is damaged","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"Some of these tests can show how well your liver is working and others can show whether your liver may be damaged by liver disease or injury.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You will probably need to fast for 10–12 hours before the test","source":{"url":"https://medlineplus.gov/lab-tests/liver-function-tests/","host":"medlineplus.gov","quote":"You will probably need to fast (not eat or drink) for 10-12 hours before the test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T5","name":"Electrolytes test","aliases":["Electrolytes test","electrolytes"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood counts, liver and kidney tests, electrolytes"}],"what_it_checks":{"text":"Checks for electrolyte, fluid, or pH imbalances","source":{"url":"https://medlineplus.gov/lab-tests/electrolyte-panel/","host":"medlineplus.gov","quote":"An electrolyte panel is used to check for electrolyte, fluid, or pH imbalances.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Blood tests","aliases":["Blood tests","recent blood tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent blood tests with liver and kidney function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"CT scan","aliases":["CT scan","CT","Chest CT"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."},{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"text":"Makes detailed pictures of the chest and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body, such as the brain, chest, and abdomen.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Chest CT or PET-CT report and images"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"Remove jewellery and other objects containing metal before the scan","source":{"url":"https://www.nhs.uk/tests-and-treatments/pet-scan/","host":"nhs.uk","quote":"You'll need to remove any jewellery and other objects containing metal.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T9","name":"Brain imaging","aliases":["Brain imaging"],"kind":"imaging","origin":[{"field":"preparation","text":"Baseline staging, usually CT with brain imaging, per the oncologist."}],"what_it_checks":{"text":"Makes detailed pictures of the brain and other body areas","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"CT scan (CAT scan) of the brain, chest, and abdomen uses a computer linked to an x-ray machine to make a series of detailed pictures of areas inside the body.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Brain MRI","aliases":["Brain MRI","MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Brain MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your treatment team whether your tumor needs biomarker testing before targeted therapy","why":"Testing shows whether the tumor has a target that a drug can attack","who_decides":"","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"visit_and_day":{"status":"ok","has_procedure_day":false,"items":[{"id":"V1","text":"Testing your cancer for targets that could help choose your treatment is called biomarker testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Testing your cancer for targets that could help choose your treatment is called biomarker testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"A biopsy is a procedure in which your doctor removes a piece of the tumor for testing.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Your doctor will explain the risks of having a biopsy for your type of tumor","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies","host":"cancer.gov","quote":"Your doctor will explain the risks of having a biopsy for your type of tumor.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells","anesthesia":"any","source":{"url":"https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq","host":"cancer.gov","quote":"Targeted therapy uses drugs or other substances to identify and attack specific cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"oral-egfr-tyrosine","name":"Oral EGFR tyrosine kinase inhibitor (osimertinib)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Adults with EGFR-mutated advanced NSCLC.","price_from":6000,"recovery":"Taken at home daily; no procedural recovery, with side-effect management and monitoring as directed."},{"id":"other-oral-targeted","name":"Other oral targeted inhibitors (ALK, ROS1, RET, MET, BRAF/MEK, KRAS G12C, HER2)","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Patients with the matching actionable alteration; the choice follows biomarker results and approvals.","price_from":5500,"recovery":"Taken at home as continuous therapy; monitoring and side effects are agent-specific."},{"id":"antibody-based-targeted","name":"Antibody-based targeted regimens, such as EGFR-MET bispecific antibody or antibody-drug conjugates","how_it_works":{"status":"missing","reason":"no_official_source"},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients with specific alterations or after progression on oral inhibitors; availability varies.","price_from":9000,"recovery":"Given by intravenous infusion in a treatment unit; schedules and observation are product-specific."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your lung cancer can be removed with surgery","name":"Lung cancer surgery","source":{"url":"https://www.nhs.uk/conditions/lung-cancer/treatment/","host":"nhs.uk","quote":"You may have surgery to remove cancer from your lung.","tier":"tier1_medical","fetched_at":"2026-11-14","http_status":200},"operation_id":374}],"checked_at":"2026-11-14","next_check_at":"2027-11-14","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British passport holders can travel to the Schengen area, which includes Germany, without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area , which includes Germany, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must have an expiry date at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V3","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport should be valid for at least 3 months beyond your period of stay when transiting a Schengen country","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"Your passport should be valid for at least 3 months beyond your period of stay if you plan on transiting a Schengen country.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"medicines","audience":"all","volatile":false,"text":"For medications Germany classifies as narcotics, you may only carry a 30-day supply","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"For medications that Germany classifies as narcotics, you may only carry a 30-day supply.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"ghic","audience":"uk","volatile":false,"text":"To get medically necessary state healthcare in Germany, UK travelers need a GHIC or an EHIC","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Germany, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Germany","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["china","egypt","india","republic-of-korea","spain","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.53,"count":167,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Target therapy for lung cancer in Germany typically costs from _op_790_price_from_ to _op_790_price_to_. The total expense depends on the specific drug protocol, molecular diagnostic results, and the clinic tier. In the US, this procedure costs _price_compare_US_average_ on average. Fees generally cover the initial consultation, diagnostic imaging, laboratory tests, and the administration of targeted medications.</p>\n\n<ul>\n<li><strong>Clinic location.</strong> Medical hubs like Frankfurt, Solingen, and Bremen offer specialized oncology centers.</li>\n<li><strong>Diagnostic requirements.</strong> Molecular testing and PET-CT imaging are necessary to identify specific genetic mutations.</li>\n<li><strong>Hospital tier.</strong> Academic teaching hospitals often have different pricing structures than regional municipal clinics.</li>\n<li><strong>Language services.</strong> International departments may charge separate hourly fees for professional medical interpreters.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight.</strong> Choosing the Medical Center in Solingen can be a strategic choice for budget planning. They offer treatments approximately 10–20% lower than the German average. This facility applies the same pricing for international and local patients. Experts like Dr. Viola Fox provide specialized molecular diagnostics for precise drug selection. Leading centers like Nordwest Clinic in Frankfurt offer ESMO-certified oncology care for complex cases.</p>","faq":[{"q":"Can international patients travel to Germany for these therapies?","a":"<p>International patients frequently travel to Germany for advanced lung cancer targeted therapy at certified interdisciplinary cancer centers. The German Cancer Society accredits these facilities, which offer molecular diagnostics and innovative drug therapies. Patients must secure a medical visa and provide an official clinic invitation for entry.</p> <ul> <li><strong>Entry visa:</strong> Patients apply for a Schengen or National visa based on treatment duration.</li> <li><strong>Mandatory documentation:</strong> Enrollment requires home country diagnosis reports and confirmed proof of financial sufficiency.</li> <li><strong>Surgical costs:</strong> Lung cancer surgery in Germany ranges from _op_374_price_from_ to _op_374_price_to_.</li> <li><strong>Diagnostic requirement:</strong> Successful targeted therapy depends on full tumor genetic profiling and molecular testing.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Academic hospitals like Solingen, affiliated with the University of Cologne, often provide deeper molecular research capabilities than private clinics. Leading specialists like Dr. Viola Fox focus on specific genetic mutations to tailor drug therapy. This academic connection allows patients access to newer agents before they reach the general market.</p> <p><strong>Patient Consensus:</strong> Accuracy in diagnostics is the most cited priority, with many patients advised to bring original pathology slides for re-testing. Coordination with international offices is essential to manage upfront costs and ensure biopsy quality meets German standards.</p>"},{"q":"Who is eligible for targeted lung cancer therapy in German clinics?","a":"<p>Eligibility for targeted lung cancer therapy in Germany depends on identifying specific genetic biomarkers through molecular diagnostics. Patients with Non-Small Cell Lung Cancer (NSCLC) qualify if their tumor expresses mutations like EGFR, ALK, ROS1, or KRAS G12C, matching European Medicines Agency approved protocols.</p> <ul> <li><strong>Biomarker matching:</strong> Patients must test positive for driver mutations like BRAF V600E, RET, or MET.</li> <li><strong>Cancer subtype:</strong> Targeted therapy primarily treats Non-Small Cell Lung Cancer, particularly adenocarcinoma subtypes.</li> <li><strong>Clinical staging:</strong> While common for Stage III/IV, some patients qualify for post-surgery adjuvant treatment.</li> <li><strong>Health status:</strong> Oncologists use ECOG scores to ensure patients can tolerate oral Tyrosine Kinase Inhibitors.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics like Medical Center in Solingen and Nordwest Clinic often utilize multidisciplinary tumor boards to confirm eligibility. Data shows these centers perform molecular profiling faster than standard hospitals. Dr. Viola Fox, a specialist in genetics at Solingen, exemplifies the high level of integration between diagnostics and targeted drug therapy available in certified German cancer centers.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that initial diagnosis is not final until comprehensive molecular profiling is complete. Many recommend keeping physical copies of pathology reports to expedite the expert review process in Germany.</p>"},{"q":"How is a patient matched to the right targeted drug in Germany?","a":"<p>Doctors match patients to targeted drugs in Germany through advanced molecular profiling and multidisciplinary review. This precise system uses Next-Generation Sequencing to identify genetic mutations like EGFR or ALK, ensuring the therapy specifically attacks cancer cells while sparing healthy tissue.</p> <ul> <li><strong>Molecular diagnostics:</strong> Surgeons perform biopsies or liquid biopsies to sequence tumor DNA and RNA.</li> <li><strong>Tumor board review:</strong> Interdisciplinary experts at centers like Solingen evaluate complex genetic data collectively.</li> <li><strong>Network Genomic Medicine:</strong> Academic centers link with community hospitals to standardize high-tech biomarker testing.</li> <li><strong>Actionable matching:</strong> Physicians use global databases and ESMO scales to select the most effective drugs.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers like Nordwest Clinic utilize internal research institutes to bridge the gap between diagnostics and drug access. While many patients focus on the drug itself, the real value lies in the biopsy quality. Large complexes like Nordrhein-Westfalen process higher volumes, which typically ensures more reliable molecular pathology results for rare mutations.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that molecular testing must occur before any drug selection to avoid ineffective treatments. They often highlight that liquid biopsies are a vital backup when traditional tissue samples are insufficient.</p>"},{"q":"What overall survival results are achieved with targeted therapy in Germany?","a":"<p>Targeted therapy in Germany significantly improves survival, with 1-year rates for advanced lung cancer reaching 79% compared to 40.2% for chemotherapy. Using molecular testing for mutations like EGFR and ALK, German oncology networks achieve median survival ranging from 18.1 to 39.6 months.</p> <ul> <li><strong>Mutation-specific outcomes:</strong> TKI therapy for lung cancer yields median survival up to 39.6 months.</li> <li><strong>Specialized diagnostics:</strong> Centers like Nordwest Clinic use molecular profiling to match precision drugs.</li> <li><strong>Blood cancer success:</strong> BTK inhibitors reduce death risk by 44% in leukemia patients.</li> <li><strong>Accredited quality:</strong> The German Cancer Society (DKG) certifies centers to ensure standard-setting administration.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics like Solingen Medical Center operate as University Academic Hospitals. This connection allows patients to access second and third-line targeted drugs immediately after progression. Our data shows that centers with interdisciplinary certification consistently provide faster molecular profiling. Early testing is the most critical factor for extending life expectancy in metastatic cases.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that targeted therapy transformed their diagnosis into a manageable chronic condition. Many report improved quality of life and hope when starting second-line drugs after initial progression.</p>"},{"q":"Which targeted drug classes are currently available in Germany?","a":"<p>Germany provides rapid access to nearly all major targeted drug classes authorized by the European Medicines Agency (EMA). Patients have access to small-molecule tyrosine kinase inhibitors, monoclonal antibodies, and antibody-drug conjugates. Specialized German oncology centers prioritize comprehensive molecular profiling to match specific genetic mutations with these precision treatments.</p> <ul> <li><strong>Kinase inhibitors:</strong> Includes EGFR, ALK, ROS1, and KRAS inhibitors for mutation-driven lung cancer treatments.</li> <li><strong>Monoclonal antibodies:</strong> Biologic drugs like HER2 antagonists and VEGF inhibitors that block tumor growth signals.</li> <li><strong>DNA-repair inhibitors:</strong> PARP and CDK4/6 inhibitors targeting specific pathways in breast and ovarian cancers.</li> <li><strong>Immune checkpoint inhibitors:</strong> Advanced therapies targeting PD-1 and CTLA-4 pathways to activate immune responses.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics like Nordwest and Solingen focus on next-generation diagnostics rather than just drug availability. Data shows top-tier facilities integrate in-house molecular biology research. This allows doctors like Dr. Viola Fox to offer newer classes like RET or MET inhibitors faster than general hospitals. Choosing a certified interdisciplinary cancer center ensures access to these research-backed drug protocols.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of early next-generation sequencing (NGS) to identify the correct drug class immediately. Most report that targeted therapies offer a better quality of life compared to traditional chemotherapy despite needing regular monitoring for side effects.</p>"},{"q":"What unique localized/combination therapies do German clinics add to targeted drugs?","a":"<p>German clinics integrate localized therapies like regional hyperthermia, insulin potentiation therapy, and electrochemotherapy with targeted drugs to override tumor resistance. These protocols utilize multidisciplinary boards at certified centers to combine systemic molecular inhibitors with precise physical interventions that increase drug penetration.</p> <ul> <li><strong>Regional hyperthermia:</strong> Focuses radiofrequency energy to heat tumors, boosting blood flow and drug delivery.</li> <li><strong>Insulin potentiation:</strong> Uses low-dose insulin to increase cancer cell sensitivity to targeted agents.</li> <li><strong>Oligoprogressive management:</strong> Combines targeted drugs with stereotactic radiation to treat specific resistant lesions.</li> <li><strong>Molecular diagnostics:</strong> Uses specialized research institutes to match patients with off-label biological protocols.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology stands out through its focus on preserving existing treatments. Data from clinics like Medical Center in Solingen and Nordwest Clinic shows surgeons and oncologists often use local ablation or radiation to treat a single growing lesion. This allows patients to continue their current targeted drug for months longer, avoiding the immediate need for more aggressive systemic changes.</p> <p><strong>Patient Consensus:</strong> Patients value the multidisciplinary team approach where thoracic surgeons and radiation experts collaborate to manage specific lung or bone spots. They frequently report that adding local therapy helps maintain a high quality of life while keeping the primary disease under control.</p>"},{"q":"Which hospitals in Germany are top-rated for neurosurgery?","a":"<p>Germany features some of the worlds most prestigious neurosurgery departments, led by Charité – Universitätsmedizin Berlin and University Hospital Heidelberg. These centers excel in treating complex brain tumors and cerebrovascular disorders. They utilize advanced technologies like intraoperative MRI and computer-assisted neuronavigation to maximize procedural success.</p> <ul> <li><strong>Charité Berlin:</strong> Performs 5,000+ surgeries annually. Led by renowned neurosurgeon Dr. Peter Vajkoczy.</li> <li><strong>Medical Center Solingen:</strong> Dr. Ralf Buhl has performed 4,000+ procedures, including minimally invasive spine surgery.</li> <li><strong>Asklepios Nord Clinic:</strong> Features Germany's only two-sided intraoperative MRI for real-time surgical precision during tumor removals.</li> <li><strong>Nordwest Clinic:</strong> Recognized by Newsweek as a leading hospital for innovations in 3D ultrasound technology.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data shows that choosing high-volume centers often leads to more conservative treatment recommendations. At Medical Center Solingen, which treats 60,000+ patients yearly, surgeons frequently suggest physiotherapy over immediate surgery if risks appear high. This volume-based expertise ensures patients only undergo operations when statistically necessary for recovery.</p> <p><strong>Patient Consensus:</strong> Patients note that German specialists are very cautious and will explain all risks before proceeding. Many emphasize the comfort of modern facilities, though some mention that having a translator is helpful for navigating administrative paperwork.</p>"},{"q":"What are the reported success rates for high-complexity neurosurgery in Germany?","a":"<p>High-complexity neurosurgery in Germany demonstrates exceptional safety. Spinal fusions reach a 99% success rate. Primary brain tumor resections maintain a 97% survival rate. Functional independence is high. Over 82% of patients discharge directly home after treatment. German centers prioritize preserving neurological function using advanced mapping.</p> <ul> <li><strong>Tumor resection:</strong> Surgeons achieve gross total resection in 87.2% of brain metastasis cases.</li> <li><strong>Vascular success:</strong> Unruptured aneurysm treatments show a 98.7% survival rate in German hospitals.</li> <li><strong>Neurological improvement:</strong> Nearly 43% of patients see functional score gains after complex resections.</li> <li><strong>Surgical safety:</strong> Spinal procedures maintain a 98–99% survival rate across major surgical centers.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume surgeons like Dr. Uwe Kehler at Asklepios Altona Clinic perform 2,000+ operations annually. Data shows these experts maintain success rates up to 90% for the most complex cerebral tumors. Choosing a specialist with 4,000+ personal surgeries, such as Dr. Ralf Buhl, ensures technical precision gathered over decades of practice.</p> <p><strong>Patient Consensus:</strong> Patients note that German surgeons often prioritize physical function over aggressive tumor removal. It is important to write down all questions in advance to make the most of short consultations with busy professors.</p>"},{"q":"What advanced technologies are routinely available in German neurosurgical clinics?","a":"<p>German neurosurgical clinics routinely integrate high-precision digital tools and real-time imaging into surgical practice. Core technologies include computer-assisted neuronavigation for brain and spinal procedures. Facilities like Asklepios Nord Clinic use intraoperative MRI to verify tumor removal in real time. These systems provide a 3D GPS for surgeons.</p> <ul> <li><strong>Neuronavigation:</strong> Provides 3D visualization and real-time instrument tracking for sub-millimeter surgical precision.</li> <li><strong>Intraoperative imaging:</strong> Systems like iMRI and O-arm CT allow immediate verification of successful resection.</li> <li><strong>Neuromonitoring:</strong> Tracks motor and sensory functions during surgery to protect the nervous system.</li> <li><strong>Fluorescence diagnostics:</strong> Uses 5-ALA dye to illuminate tumor borders for more complete removal.</li> <li><strong>Robotic assistance:</strong> Systems like Da Vinci enhance dexterity for complex minimally invasive procedures.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume centers like Charité – Universitätsmedizin Berlin perform 4,000+ neurosurgeries annually, creating a data-rich environment for refining robotic protocols. Medical Center in Solingen offers specialized packages for herniated disc surgery including preoperative diagnostics. This volume allows German clinics to negotiate better rates for consumables, keeping advanced tech accessible.</p> <p><strong>Patient Consensus:</strong> Patients note that modern German clinics significantly reduce recovery times compared to older surgical methods. Many describe the experience as less painful due to smaller incisions and highly competent staff who explain every technical risk clearly.</p>"},{"q":"What specialist training do practicing neurosurgeons in Germany complete?","a":"<p>Neurosurgeons in Germany must complete 6 years of specialized residency training after medical school. This structured program includes intensive care, clinical practice, and a mandatory surgical log. Candidates then pass a state board exam to earn the title Facharzt für Neurochirurgie.</p> <ul> <li><strong>Clinical residency:</strong> Requires 48 to 72 months of dedicated neurosurgical practice.</li> <li><strong>Intensive care:</strong> Includes mandatory 6-month rotation in a neurosurgical intensive care unit.</li> <li><strong>Surgical log:</strong> Surgeons document hundreds of procedures, including craniotomies and spinal surgeries.</li> <li><strong>Board examination:</strong> Candidates must pass a state-administered oral and practical medical assessment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German neurosurgery training emphasizes high-volume surgical experience. For example, Dr. Ralf Buhl at Medical Center in Solingen has performed 4,000+ surgeries. Dr. Jürgen Kiwit at Meoclinic Hospital brings 25+ years of expertise. This rigorous system ensures that specialists at major centers manage complex cases with proven precision.</p> <p><strong>Patient Consensus:</strong> Patients feel confident knowing their doctors underwent years of strict, state-monitored training. Many note that the detailed documentation of a surgeon's past procedures provides significant peace of mind before surgery.</p>"},{"q":"What language and licensure requirements apply to international surgeons aiming to train or observe neurosurgery cases in Germany?","a":"<p>International neurosurgeons must meet strict language and licensure standards to train or observe in Germany. Training requires a full medical license or temporary permit. Observers need hospital-specific approval. Both paths demand high-level German proficiency to participate in clinical discussions and follow complex surgical protocols safely.</p> <ul> <li><strong>Language proficiency:</strong> General German B2 and medical C1 (Fachsprachprüfung) are mandatory for clinical training.</li> <li><strong>Clinical licensure:</strong> Surgeons need Approbation for permanent practice or Berufserlaubnis for temporary supervised training.</li> <li><strong>Observation status:</strong> A Hospitation allows observing surgeries without medical responsibility or a formal license.</li> <li><strong>Credential evaluation:</strong> Non-EU graduates often face a 3–6 month process to verify their medical degrees.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics with high patient volumes, like Nordwest Clinic or Asklepios Nord, often prioritize candidates who have already secured their preliminary document evaluation. Our data shows that professors like Dr. Uwe Kehler and Dr. Paul Kremer manage thousands of cases annually. Demonstrating German B2 level early can bypass many bureaucratic delays in these busy departments.</p> <p><strong>Patient Consensus:</strong> Patients note that the language barrier is significant. They emphasize that while some international staff help, having a translator or a German-speaking doctor is vital for clear communication.</p>"},{"q":"Does Germany have enough neurosurgeons to handle both domestic and international patient volumes?","a":"<p>Germany maintains the highest density of neurosurgeons in Europe with 2.94 specialists per 100,000 residents. This robust workforce easily manages international volumes through 184 dedicated departments. Key facilities like Charite Berlin perform 4,000+ surgeries annually. High specialist availability ensures additional capacity for complex global cases.</p> <ul> <li><strong>Specialist density:</strong> Germany has 2.94 neurosurgeons per 100,000 people, doubling the European average.</li> <li><strong>Clinical infrastructure:</strong> Over 182 dedicated neurosurgical departments provide widespread geographic access across Germany.</li> <li><strong>Surgical expertise:</strong> Prof. Dr. Peter Vajkoczy at Charite Berlin leads over 4,000 annual procedures.</li> <li><strong>Advanced technology:</strong> Facilities like Asklepios Nord Clinic utilize intraoperative MRI and computerized neuronavigation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Germany has high specialist numbers, top-tier professors like Dr. Ralf Buhl or Dr. Uwe Kehler are often concentrated in major hubs like Hamburg or Solingen. Our data shows these high-volume centers actually offer faster access for international patients than smaller clinics. Large academic hospitals maintain dedicated tracks for complex cases, effectively bypassing local capacity bottlenecks found in rural areas.</p> <p><strong>Patient Consensus:</strong> Patients often note that while surgeons are highly professional, clear communication about reports can sometimes take time. One patient mentioned that recovery periods in German clinics are now much shorter and less painful than in previous decades.</p>"}],"h2":[{"text":"Какая цена таргетной терапии при раке легких в Германии?","kind":"content"},{"text":"Преимущества и гарантии Bookimed","kind":"content"},{"text":"Ваш личный врач-координатор Bookimed","kind":"content"},{"text":"Лучшие клиники по Таргетная терапия при раке легких в Германии — 5 проверенных вариантов с ценами","kind":"content"},{"text":"Обзор процедуры Таргетная терапия при раке легких в Германии","kind":"content"},{"text":"Получите медицинскую консультацию по Таргетная терапия при раке легких в Германии: Выбирайте среди лучших специалистов в этой области","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по Таргетная терапия при раке легких в Германии","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}